StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd.

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)

Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –

BeOne Medicines Deferred Income Tax Liabilities, Net by Quarter

Deferred Income Tax Liabilities, Net ($M) ($M)

BeOne Medicines Deferred Income Tax Liabilities, Net: $57.4M in Q2 2026, up 30.2% from a year earlier. That is the highest of the 32 quarters on record here.

Latest, Q2 2026
57.4
Period ended Jun 30, 2026
Change on a year earlier
+30.2%
44.1 in Q2 2025
History
32 quarters
Since Q4 2017
Sources
31
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Income Taxes Note (XBRL).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedDeferred Income Tax Liabilities, Net ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202657.4+30.2%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 202655.9+29.7%Form 10-Q (filed 2026-05-06) ↗
Q4 2025Dec 31, 202553.2+26.7%Form 10-Q (filed 2026-08-05) ↗
Q3 2025Sep 30, 202547.1+196.2%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 202544.1+177.4%Form 10-Q (filed 2025-08-06) ↗
Q1 2025Mar 31, 202543.1+162.8%Form 10-Q (filed 2025-05-07) ↗
Q4 2024Dec 31, 202442+154.5%Form 10-K (filed 2026-02-26) ↗
Q3 2024Sep 30, 202415.9-3.0%Form 10-Q (filed 2024-11-12) ↗
Q2 2024Jun 30, 202415.9+1.3%Form 10-Q (filed 2024-08-07) ↗
Q1 2024Mar 31, 202416.4+1.9%Form 10-Q (filed 2024-05-08) ↗
Q4 2023Dec 31, 202316.5+3.1%Form 10-K (filed 2025-02-27) ↗
Q3 2023Sep 30, 202316.4+7.9%Form 10-Q (filed 2023-11-09) ↗
Q2 2023Jun 30, 202315.7+6.8%Form 10-Q (filed 2023-08-02) ↗
Q1 2023Mar 31, 202316.1+13.4%Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 202216+12.7%Form 10-K (filed 2024-02-26) ↗
Q3 2022Sep 30, 202215.2+14.3%Form 10-Q (filed 2022-11-09) ↗

Cite this data

StockData. (2026). BeOne Medicines Deferred Income Tax Liabilities, Net ($M), quarterly Q4 2017–Q2 2026 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/dtl-net

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.